AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Aims Anticoagulants are the mainstay treatment for stroke prevention in patients with non-
valvular atrial fibrillation (NVAF), and the CHA2DS2-VASc score is widely used to guide …

The field of left atrial appendage occlusion is rapidly evolving. However, several issues
remain including the limited randomized efficacy data, peri-device leak, device-related …

Machine learning applications in cardiology have rapidly evolved in the past decade. With
the availability of machine learning tools coupled with vast data sources, the management of …

Atrial fibrillation (AF) is the most common sustained arrhythmia. Individuals with AF have a 5-
fold increased risk of stroke, 3-fold increased risk of heart failure, and almost 2-fold …

Background Occult atrial fibrillation (AF) is an important contributor to cryptogenic stroke, yet
remains difficult to unmask at presentation. This study investigated the predictive value of left …

Aims The aim of this study is to summarize data from prospective cohort studies on clinical
predictors of stroke and systemic embolism in anticoagulant-naïve atrial fibrillation (AF) …

Background Atrial fibrillation (AF) represents the most common clinical cardiac arrhythmia
and substantially increases the risk of cerebral stroke, heart failure, and death. Although …

The disease burden of AF is greater in Asia-Pacific than other areas of the world. Direct oral
anticoagulants (DOACs) have emerged as effective alternatives to vitamin K antagonists …